The majority of HSPB8 mutations have been identified in patients with Charcot–Marie–Tooth (CMT) type 2L [42,43], myopathy, and distal hereditary motor neuropathy (dHMN) type IIa [44,45,46]. This evidence concerns the gene HSPB8 and distal hereditary motor neuropathy.